Molina Healthcare, Inc. (MOH) trades at a trailing P/E of 15.7, forward P/E of 29.3. Trailing earnings yield is 6.35%, forward earnings yield 3.41%. PEG 0.59 (Peter Lynch undervalued ≤1.0). Graham Number is $129.42.
Criteria proven by this page:
Overall SharesGrow Score: 59/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | 373.0 | -5.64 | 1.81 | 0.17 | - |
| 2017 | -8.4 | 0.01 | 3.21 | 0.22 | - |
| 2018 | 11.0 | -0.05 | 4.70 | 0.41 | - |
| 2019 | 11.5 | 0.98 | 4.31 | 0.50 | - |
| 2020 | 18.6 | -5.02 | 5.99 | 0.65 | - |
| 2021 | 27.9 | -318.32 | 6.99 | 0.66 | - |
| 2022 | 24.1 | 1.19 | 6.44 | 0.60 | - |
| 2023 | 19.2 | 0.53 | 4.98 | 0.62 | - |
| 2024 | 14.2 | 1.46 | 3.72 | 0.41 | - |
| 2025 | 18.7 | -0.33 | 2.17 | 0.19 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $0.92 | $17.71B | $8M | 0% |
| 2017 | $-9.14 | $19.88B | $-512M | -2.6% |
| 2018 | $10.55 | $18.89B | $707M | 3.7% |
| 2019 | $11.48 | $16.83B | $737M | 4.4% |
| 2020 | $11.24 | $19.42B | $673M | 3.5% |
| 2021 | $11.25 | $27.77B | $659M | 2.4% |
| 2022 | $13.54 | $31.97B | $792M | 2.5% |
| 2023 | $18.78 | $34.07B | $1.09B | 3.2% |
| 2024 | $20.42 | $40.65B | $1.18B | 2.9% |
| 2025 | $8.92 | $45.43B | $472M | 1% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $5.04 | $5.00 – $5.12 | $44.72B | $42.93B – $45.27B | 11 |
| 2027 | $8.38 | $7.56 – $10.98 | $46.97B | $43.79B – $51.66B | 7 |
| 2028 | $12.38 | $10.40 – $13.38 | $49.09B | $49.06B – $49.12B | 4 |
| 2029 | $17.32 | $16.13 – $18.80 | $49.94B | $47.32B – $53.22B | 2 |
| 2030 | $25.38 | $23.65 – $27.55 | $52.76B | $49.99B – $56.22B | 2 |
